Announcements Trials

Browse Landscape

Phase

Status

Terminated 2 No longer available 2 Recruiting 1 Approved for marketing 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Diffuse Intrinsic Pontine Glioma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Obesity 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Glioma 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Disease 1 Carcinosarcoma 1

Interventions

Magnetic Resonance Spectroscopy 19 Temozolomide 16 Radiotherapy 10 Specimen Handling 7 Blood Specimen Collection 7 Radiation 6 Bevacizumab 5 Nivolumab 4 Cyclophosphamide 4 Biopsy 4 vorasidenib 3 trametinib 3 pembrolizumab 3 olaparib 3 fludarabine 3 dabrafenib 3 Watchful Waiting 3 Surgical Procedures, Operative 3 Magnetic Resonance Imaging 3 Drug Therapy 3 olutasidenib 2 lutetium Lu 177 dotatate 2 fluorodopa F 18 2 fluciclovine F-18 2 entrectinib 2 contrast agent BR1 2 Restraint, Physical 2 Radiosurgery 2 Microdialysis 2 Flucytosine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Glioma × TIC10 compound × Clear all

NCT05580562 2026-04-16

ACTION

Jazz Pharmaceuticals

Phase 3 Recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡